TherapeuticsMD (TXMD) Receivables - Net (2010 - 2025)
TherapeuticsMD's (TXMD) quarterly Receivables - Net came in at $17.2 million in Q4 2025, down 11.93% YoY from $19.6 million in Q4 2024, and down 11.93% on a QoQ basis from $19.6 million in Q4 2024.
TherapeuticsMD (TXMD) Receivables - Net (2010 - 2025) Analysis & Trends
TherapeuticsMD (TXMD) has 16 years of Receivables - Net data on file, last reported at $17.2 million in Q4 2025.
- Quarterly Receivables - Net fell 11.93% year-over-year to $17.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $17.2 million (down 11.93% YoY) and the FY2025 annual result came in at $17.2 million, down 11.93% from the prior year.
- Receivables - Net retreated to $17.2 million in Q4 2025, from $19.6 million in the prior quarter.
- In the past five years, Receivables - Net ranged from a high of $45.8 million in Q2 2022 to a low of $17.2 million in Q4 2025.
- A 5-year average of $31.3 million and a median of $33.6 million in 2021 frame the typical range for Receivables - Net.
- Annual changes were most pronounced in 2021 — Receivables - Net surged 83.05% — and 2022, when it retreated 14.02%.
- Tracing TXMD's Receivables - Net over 5 years: stood at $36.2 million in 2021, then declined by 11.11% to $32.2 million in 2022, then plunged by 32.91% to $21.6 million in 2023, then retreated by 9.28% to $19.6 million in 2024, then declined by 11.93% to $17.2 million in 2025.
- The last three Receivables - Net figures came in at $17.2 million (Q4 2025), $19.6 million (Q4 2024), and $21.6 million (Q4 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.23 Bn | 43.26 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.55 Bn | 39.89 Bn | 2.15 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.64 Bn | 22.85 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.37 Bn | 19.71 Bn | 683.80 Mn |
| 6 | Viatris | 18.84 Bn | 17.95 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.55 Bn | 15.16 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.91 Bn | 11.38 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - |
| 10 | TherapeuticsMD | 23.84 Mn | 14.65 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 17.24 Mn |
| Dec 31, 2025 | 17.24 Mn |
| Dec 31, 2024 | 19.57 Mn |
| Dec 31, 2024 | 19.57 Mn |
| Dec 31, 2023 | 21.57 Mn |
| Dec 31, 2023 | 21.57 Mn |
| Sep 30, 2022 | 32.16 Mn |
| Sep 30, 2022 | 32.16 Mn |
| Jun 30, 2022 | 45.80 Mn |
| Jun 30, 2022 | 45.80 Mn |
| Mar 31, 2022 | 35.41 Mn |
| Mar 31, 2022 | 35.41 Mn |
| Dec 31, 2021 | 36.18 Mn |
| Dec 31, 2021 | 36.18 Mn |
| Sep 30, 2021 | 37.40 Mn |
| Sep 30, 2021 | 37.40 Mn |
| Jun 30, 2021 | 33.48 Mn |
| Jun 30, 2021 | 33.48 Mn |
| Mar 31, 2021 | 33.72 Mn |
| Mar 31, 2021 | 33.72 Mn |